Changchun GeneScience Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT05353192
- Locations
- 🇨🇳
Children's Hospital of Fudan University, Shanghai, Shanghai, China
Clinical Study of Genakumab for Injection in Patients With Acute Gout
- Conditions
- Interventions
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 121
- Registration Number
- NCT05328531
- Locations
- 🇨🇳
Shanghai Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT05263271
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT05223595
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT05221385
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
🇨🇳Jian Zhang, Shanghai, Shanghai, China
Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04337437
- Locations
- 🇨🇳
Clinical Pharmacology Research Center of Peking Union Medical College Hospital, Beijing, China
A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer
- Conditions
- Interventions
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 76
- Registration Number
- NCT04053205
- Locations
- 🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China
🇨🇳Fujian Tumor Hospital, Fuzhou, Fujian, China
🇨🇳The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 480
- Registration Number
- NCT03635580
- Locations
- 🇨🇳
Henan Children's Hospital, Zhengzhou, Henan, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
🇨🇳The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
- Conditions
- Interventions
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03554031
- Locations
- 🇨🇳
Peking union medical college hospital, Beijing, China
🇨🇳Beijing Children's Hospital, Capital Medical University, Beijing, China
🇨🇳Peking university first hospital, Beijing, China
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 68
- Registration Number
- NCT03535415
- Locations
- 🇨🇳
Fuzhou general hospital of Nanjing military command, Fuzhou, Fujian, China
🇨🇳The first affiliated hospital of zhengzhou university, Zhengzhou, Henan, China
🇨🇳Tongji medical college huazhong university of science & technology, Wuhan, Hubei, China